Janssen Enters Collaboration with Bavarian Nordic to Develop Vaccines Against Hepatitis B Virus and HIV-1

Collaboration to combine Janssen ’s vaccine technologies with MVA-BN® technology from Bavarian Nordic to advance potential new vaccine regimens
Source: Johnson and Johnson - Category: Pharmaceuticals Source Type: news